ARM 2 – ChemoID-guided drug response assay chemotherapy regimens
cancer, tumor
CANCER, TUMOR
The physician selected a treatment regimen based on ChemoID drug response assay results on cancer stem cells (CSC) and the bulk of tumor cells. Ideally, the regimen with the highest percentage cell-kill for cancer stem cells and the bulk of tumor combined was used; however, the physician had the flexibility to choose the best regimen according to anticipated patient tolerability. The regimens tested by the ChemoID drug response assay are the same as the ones that can be chosen by the Physician for patients enrolled in Arm 1.